Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis.

Ciccia F, Alessandro R, Rizzo A, Raimondo S, Giardina A, Raiata F, Boiardi L, Cavazza A, Guggino G, De Leo G, Salvarani C, Triolo G.

Ann Rheum Dis. 2013 Feb;72(2):258-64. doi: 10.1136/annrheumdis-2012-201309. Epub 2012 Aug 7. Erratum in: Ann Rheum Dis. 2015 May;74(5):920.

PMID:
22872024
2.

Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis.

Ciccia F, Rizzo A, Guggino G, Cavazza A, Alessandro R, Maugeri R, Cannizzaro A, Boiardi L, Iacopino DG, Salvarani C, Triolo G.

Rheumatology (Oxford). 2015 Sep;54(9):1596-604. doi: 10.1093/rheumatology/kev102. Epub 2015 Apr 9.

PMID:
25862016
3.

Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.

Espígol-Frigolé G, Corbera-Bellalta M, Planas-Rigol E, Lozano E, Segarra M, García-Martínez A, Prieto-González S, Hernández-Rodríguez J, Grau JM, Rahman MU, Cid MC.

Ann Rheum Dis. 2013 Sep 1;72(9):1481-7. doi: 10.1136/annrheumdis-2012-201836. Epub 2012 Sep 19.

PMID:
22993227
4.

Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.

Hernández-Rodríguez J, Segarra M, Vilardell C, Sánchez M, García-Martínez A, Esteban MJ, Queralt C, Grau JM, Urbano-Márquez A, Palacín A, Colomer D, Cid MC.

Rheumatology (Oxford). 2004 Mar;43(3):294-301. Epub 2003 Dec 16.

PMID:
14679293
5.

Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism.

Hernández-Rodríguez J, Segarra M, Vilardell C, Sánchez M, García-Martínez A, Esteban MJ, Grau JM, Urbano-Márquez A, Colomer D, Kleinman HK, Cid MC.

Circulation. 2003 May 20;107(19):2428-34. Epub 2003 May 12.

6.

DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis.

Coit P, De Lott LB, Nan B, Elner VM, Sawalha AH.

Ann Rheum Dis. 2016 Jun;75(6):1196-202. doi: 10.1136/annrheumdis-2014-207116. Epub 2015 Jun 2.

PMID:
26038090
7.

Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures.

Blain H, Abdelmouttaleb I, Belmin J, Blain A, Floquet J, Guéant JL, Jeandel C.

J Gerontol A Biol Sci Med Sci. 2002 Apr;57(4):M241-5.

PMID:
11909890
8.

Disease patterns and tissue cytokine profiles in giant cell arteritis.

Weyand CM, Tetzlaff N, Björnsson J, Brack A, Younge B, Goronzy JJ.

Arthritis Rheum. 1997 Jan;40(1):19-26.

PMID:
9008596
9.

Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.

Baldini M, Maugeri N, Ramirez GA, Giacomassi C, Castiglioni A, Prieto-González S, Corbera-Bellalta M, Di Comite G, Papa I, Dell'antonio G, Ammirati E, Cuccovillo I, Vecchio V, Mantovani A, Rovere-Querini P, Sabbadini MG, Cid MC, Manfredi AA.

Arthritis Rheum. 2012 Mar;64(3):854-65. doi: 10.1002/art.33411. Erratum in: Arthritis Rheum. 2012 May;64(5):1487.

10.

Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis.

Ciccia F, Alessandro R, Rizzo A, Principe S, Raiata F, Cavazza A, Guggino G, Accardo-Palumbo A, Boiardi L, Ferrante A, Principato A, Giardina A, De Leo G, Salvarani C, Triolo G.

Arthritis Rheum. 2011 Jul;63(7):2097-104. doi: 10.1002/art.30374.

11.

Estrogen receptors in giant cell arteritis. An immunocytochemical, western blot and RT-PCR study.

Petursdottir V, Nordborg E, Moraghebi N, Persson M, Nordborg C.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6):671-7.

PMID:
10609065
12.

Giant cell vasculitis is a T cell-dependent disease.

Brack A, Geisler A, Martinez-Taboada VM, Younge BR, Goronzy JJ, Weyand CM.

Mol Med. 1997 Aug;3(8):530-43.

13.

Increased tissue endothelin-1 and endothelin-B receptor expression in temporal arteries from patients with giant cell arteritis.

Dimitrijevic I, Andersson C, Rissler P, Edvinsson L.

Ophthalmology. 2010 Mar;117(3):628-36. doi: 10.1016/j.ophtha.2009.07.043. Epub 2009 Dec 24.

PMID:
20036012
14.

Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

Terrier B, Geri G, Chaara W, Allenbach Y, Rosenzwajg M, Costedoat-Chalumeau N, Fouret P, Musset L, Benveniste O, Six A, Klatzmann D, Saadoun D, Cacoub P.

Arthritis Rheum. 2012 Jun;64(6):2001-11. doi: 10.1002/art.34327. Epub 2011 Dec 6.

15.

Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis.

Dimitrijevic I, Malmsjö M, Andersson C, Rissler P, Edvinsson L.

Ophthalmology. 2009 May;116(5):990-6. doi: 10.1016/j.ophtha.2008.12.021.

PMID:
19410957
16.

Regulation of Inflammation and Angiogenesis in Giant Cell Arteritis by Acute-Phase Serum Amyloid A.

O'Neill L, Rooney P, Molloy D, Connolly M, McCormick J, McCarthy G, Veale DJ, Murphy CC, Fearon U, Molloy E.

Arthritis Rheumatol. 2015 Sep;67(9):2447-56. doi: 10.1002/art.39217.

17.

NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.

Dejaco C, Duftner C, Al-Massad J, Wagner AD, Park JK, Fessler J, Aigelsreiter A, Hafner F, Vega S, Sterlacci W, Grubeck-Loebenstein B, Tzankov A, Ness T, Boiardi L, Salvarani C, Schirmer M.

Ann Rheum Dis. 2013 Nov;72(11):1852-9. doi: 10.1136/annrheumdis-2012-201660. Epub 2013 Feb 15.

PMID:
23417963
18.

Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.

Ly KH, Régent A, Molina E, Saada S, Sindou P, Le-Jeunne C, Brézin A, Witko-Sarsat V, Labrousse F, Robert PY, Bertin P, Bourges JL, Fauchais AL, Vidal E, Mouthon L, Jauberteau MO.

Arthritis Res Ther. 2014 Nov 24;16(6):487. doi: 10.1186/s13075-014-0487-z.

19.

Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.

Corbera-Bellalta M, Planas-Rigol E, Lozano E, Terrades-García N, Alba MA, Prieto-González S, García-Martínez A, Albero R, Enjuanes A, Espígol-Frigolé G, Hernández-Rodríguez J, Roux-Lombard P, Ferlin WG, Dayer JM, Kosco-Vilbois MH, Cid MC.

Ann Rheum Dis. 2016 Jun;75(6):1177-86. doi: 10.1136/annrheumdis-2015-208371. Epub 2015 Dec 23.

PMID:
26698852
20.

Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events.

Lozano E, Segarra M, Corbera-Bellalta M, García-Martínez A, Espígol-Frigolé G, Plà-Campo A, Hernández-Rodríguez J, Cid MC.

Ann Rheum Dis. 2010 Feb;69(2):434-42. doi: 10.1136/ard.2008.105692. Epub 2009 Mar 15.

PMID:
19289383

Supplemental Content

Support Center